Item Type | Name |
Concept
|
Cytokines
|
Concept
|
Piperazines
|
Concept
|
Enzyme-Linked Immunosorbent Assay
|
Concept
|
Extracellular Matrix
|
Concept
|
Age Factors
|
Concept
|
Disease Models, Animal
|
Concept
|
Fibroblasts
|
Concept
|
Drug Administration Schedule
|
Concept
|
Sequence Analysis, DNA
|
Concept
|
Maleimides
|
Concept
|
Elastin
|
Concept
|
Electrocardiography, Ambulatory
|
Concept
|
Informed Consent
|
Concept
|
Magnetic Resonance Imaging, Cine
|
Concept
|
Transforming Growth Factor beta
|
Concept
|
Bone Development
|
Concept
|
Diagnostic Techniques, Cardiovascular
|
Concept
|
Blood Pressure
|
Concept
|
Kaplan-Meier Estimate
|
Concept
|
Genetic Association Studies
|
Concept
|
Cell Lineage
|
Concept
|
Equipment Failure
|
Concept
|
False Negative Reactions
|
Concept
|
Incidence
|
Concept
|
Proportional Hazards Models
|
Concept
|
Genes, Tumor Suppressor
|
Concept
|
Electric Countershock
|
Concept
|
Heterozygote
|
Concept
|
Morbidity
|
Concept
|
Marfan Syndrome
|
Concept
|
Epistasis, Genetic
|
Concept
|
Magnetic Resonance Imaging
|
Concept
|
Age of Onset
|
Concept
|
Drug Therapy, Combination
|
Concept
|
Practice Guidelines as Topic
|
Concept
|
Pyrazoles
|
Concept
|
Loeys-Dietz Syndrome
|
Concept
|
Desmogleins
|
Concept
|
Cadherins
|
Concept
|
Sensitivity and Specificity
|
Concept
|
Death, Sudden, Cardiac
|
Concept
|
Aorta, Thoracic
|
Concept
|
Single-Blind Method
|
Concept
|
Heart Transplantation
|
Concept
|
Registries
|
Concept
|
Treatment Outcome
|
Concept
|
Brugada Syndrome
|
Concept
|
Genes, Dominant
|
Concept
|
Genomics
|
Concept
|
Clinical Trials, Phase III as Topic
|
Concept
|
Administration, Oral
|
Concept
|
Child Development
|
Concept
|
NIH 3T3 Cells
|
Concept
|
Protein Kinase Inhibitors
|
Concept
|
Genetic Testing
|
Concept
|
Confidence Intervals
|
Concept
|
Genetics
|
Concept
|
Thrombocytopenia
|
Concept
|
Amino Acid Substitution
|
Concept
|
Chi-Square Distribution
|
Concept
|
Interviews as Topic
|
Concept
|
Apoptosis Inducing Factor
|
Concept
|
Feasibility Studies
|
Concept
|
Heparin
|
Concept
|
Mitogen-Activated Protein Kinase 1
|
Concept
|
Electrophysiology
|
Concept
|
Magnetic Resonance Angiography
|
Concept
|
Double-Blind Method
|
Concept
|
Statistics as Topic
|
Concept
|
Disease-Free Survival
|
Concept
|
Algorithms
|
Concept
|
Mice, Knockout
|
Concept
|
Cohort Studies
|
Concept
|
Antibodies
|
Concept
|
Coronary Artery Disease
|
Concept
|
Mortality
|
Concept
|
Platelet Factor 4
|
Concept
|
Clinical Trials, Phase II as Topic
|
Concept
|
Chromosomes, Human, Pair 4
|
Concept
|
Propranolol
|
Concept
|
Pancreatic Neoplasms
|
Concept
|
Smad2 Protein
|
Concept
|
Ventricular Remodeling
|
Concept
|
Genetics, Medical
|
Concept
|
Genetic Predisposition to Disease
|
Concept
|
Syncope
|
Concept
|
Muscular Dystrophy, Emery-Dreifuss
|
Concept
|
Microfibrils
|
Concept
|
Observer Variation
|
Concept
|
Biopsy
|
Concept
|
Cardiac Output
|
Concept
|
Up-Regulation
|
Concept
|
Early Diagnosis
|
Concept
|
Stroke Volume
|
Concept
|
Logistic Models
|
Concept
|
Prealbumin
|
Concept
|
Mice
|
Concept
|
Clinical Trials as Topic
|
Concept
|
Aging
|
Concept
|
Equipment Failure Analysis
|
Concept
|
Immunoglobulin kappa-Chains
|
Concept
|
Diastole
|
Concept
|
Genetic Variation
|
Concept
|
Emergency Service, Hospital
|
Concept
|
Early Termination of Clinical Trials
|
Concept
|
Tensile Strength
|
Concept
|
Barth Syndrome
|
Concept
|
Linear Models
|
Concept
|
Lung Diseases
|
Concept
|
Mitogen-Activated Protein Kinase 3
|
Concept
|
Hypertrophy, Left Ventricular
|
Concept
|
Echocardiography
|
Concept
|
Microscopy, Confocal
|
Concept
|
Fat Necrosis
|
Concept
|
Pacemaker, Artificial
|
Concept
|
Scleroderma, Systemic
|
Concept
|
Cardiac Catheterization
|
Concept
|
Haplotypes
|
Concept
|
Dopamine
|
Concept
|
Matrix Metalloproteinase 9
|
Concept
|
Matrix Metalloproteinase 2
|
Concept
|
Defibrillators, Implantable
|
Concept
|
Mice, Inbred C57BL
|
Concept
|
Polycystic Kidney, Autosomal Dominant
|
Concept
|
Retrospective Studies
|
Concept
|
Gene Expression Regulation
|
Concept
|
Enzyme Activation
|
Concept
|
Models, Statistical
|
Concept
|
Isolated Noncompaction of the Ventricular Myocardium
|
Concept
|
Mice, Transgenic
|
Concept
|
Zebrafish Proteins
|
Concept
|
Multivariate Analysis
|
Concept
|
Mitogen-Activated Protein Kinase 14
|
Concept
|
Biomechanical Phenomena
|
Concept
|
Diphenylamine
|
Concept
|
Antigens, CD
|
Concept
|
Cicatrix
|
Concept
|
Mole Rats
|
Concept
|
Heart Rate
|
Concept
|
DNA Mutational Analysis
|
Concept
|
Hydralazine
|
Concept
|
Exercise
|
Concept
|
RNA Splice Sites
|
Concept
|
Severity of Illness Index
|
Concept
|
Cell Proliferation
|
Concept
|
Survival Rate
|
Concept
|
Pedigree
|
Concept
|
Humans
|
Concept
|
Sequence Analysis, RNA
|
Concept
|
Likelihood Functions
|
Concept
|
Desmocollins
|
Concept
|
Mutation
|
Concept
|
Radionuclide Imaging
|
Concept
|
Chromosomes, Human, Pair 15
|
Concept
|
Adaptor Proteins, Signal Transducing
|
Concept
|
Cardiomegaly
|
Concept
|
Electrophoresis
|
Concept
|
Longitudinal Studies
|
Concept
|
Candida glabrata
|
Concept
|
Calpain
|
Concept
|
Heredity
|
Concept
|
Heart-Assist Devices
|
Concept
|
Ventricular Function, Left
|
Concept
|
Protein Modification, Translational
|
Concept
|
Mitogen-Activated Protein Kinase 8
|
Concept
|
Fatal Outcome
|
Concept
|
Health Services Needs and Demand
|
Concept
|
Cause of Death
|
Concept
|
Genes, Mitochondrial
|
Concept
|
Diabetic Neuropathies
|
Concept
|
Neutralization Tests
|
Concept
|
Microsatellite Repeats
|
Concept
|
Muscular Dystrophy, Duchenne
|
Concept
|
Positron-Emission Tomography
|
Concept
|
Health Care Costs
|
Concept
|
Glucagonoma
|
Concept
|
Survival Analysis
|
Concept
|
Systole
|
Concept
|
Sex Factors
|
Concept
|
Respiration, Artificial
|
Concept
|
Analysis of Variance
|
Concept
|
Reverse Transcriptase Polymerase Chain Reaction
|
Concept
|
Atherosclerosis
|
Concept
|
Benzoates
|
Concept
|
Molecular Diagnostic Techniques
|
Concept
|
Smad4 Protein
|
Concept
|
Sequence Alignment
|
Concept
|
Genome, Human
|
Concept
|
Desmoglein 3
|
Concept
|
Interferon-alpha
|
Concept
|
Friedreich Ataxia
|
Concept
|
Angiotensin-Converting Enzyme Inhibitors
|
Concept
|
Genetic Counseling
|
Concept
|
Mass Screening
|
Concept
|
Genotype
|
Concept
|
Cardiomyopathy, Hypertrophic, Familial
|
Concept
|
Polymorphism, Genetic
|
Concept
|
Ehlers-Danlos Syndrome
|
Concept
|
Medical History Taking
|
Concept
|
Graft Rejection
|
Concept
|
Prevalence
|
Concept
|
Case-Control Studies
|
Concept
|
Monoclonal Gammopathy of Undetermined Significance
|
Concept
|
Hemodynamics
|
Concept
|
Body Surface Potential Mapping
|
Concept
|
Electrophysiologic Techniques, Cardiac
|
Concept
|
Predictive Value of Tests
|
Concept
|
Reproducibility of Results
|
Concept
|
Sweat Glands
|
Concept
|
Prospective Studies
|
Concept
|
Fabry Disease
|
Concept
|
Amyloid Neuropathies, Familial
|
Concept
|
Cross-Sectional Studies
|
Concept
|
Collagen
|
Concept
|
Biphenyl Compounds
|
Concept
|
Codon, Nonsense
|
Concept
|
Randomized Controlled Trials as Topic
|
Concept
|
Progeria
|
Concept
|
Genome-Wide Association Study
|
Concept
|
Losartan
|
Concept
|
Proteomics
|
Concept
|
Consensus
|
Concept
|
Creatinine
|
Concept
|
RNA Splicing
|
Concept
|
Surveys and Questionnaires
|
Concept
|
Enzyme Inhibitors
|
Concept
|
Tomography, X-Ray Computed
|
Concept
|
Rats, Wistar
|
Concept
|
Myotonic Dystrophy
|
Concept
|
Glucocorticoids
|
Concept
|
Fluoroscopy
|
Concept
|
Transfection
|
Concept
|
Point Mutation
|
Concept
|
Nicotinic Acids
|
Concept
|
Gene Frequency
|
Concept
|
Muscular Dystrophies, Limb-Girdle
|
Concept
|
Desmoglein 2
|
Concept
|
Cardiac Pacing, Artificial
|
Concept
|
Polymerase Chain Reaction
|
Concept
|
Indazoles
|
Concept
|
Polyploidy
|
Concept
|
Ethylenediamines
|
Concept
|
Exercise Test
|
Concept
|
Myocardial Contraction
|
Concept
|
Ultrasonography
|
Concept
|
Gene Deletion
|
Concept
|
Cell Shape
|
Concept
|
Epicardial Mapping
|
Concept
|
Risk Assessment
|
Concept
|
In Situ Hybridization, Fluorescence
|
Concept
|
Mutation, Missense
|
Concept
|
Enalapril
|
Concept
|
Risk
|
Concept
|
Risk Factors
|
Concept
|
Immunoglobulin lambda-Chains
|
Concept
|
Base Sequence
|
Concept
|
Alleles
|
Concept
|
Follow-Up Studies
|
Concept
|
Autopsy
|
Concept
|
Immunohistochemistry
|
Concept
|
Drug Combinations
|
Concept
|
Mice, Mutant Strains
|
Concept
|
Rats, Transgenic
|
Concept
|
Electrocardiography
|
Concept
|
Diagnostic Errors
|
Concept
|
Ventricular Function, Right
|
Concept
|
Tetrazoles
|
Academic Article
|
Right ventricular afterload sensitivity dramatically increases after left ventricular assist device implantation: A multi-center hemodynamic analysis.
|
Academic Article
|
Angiotensin II antagonism is associated with reduced risk for gastrointestinal bleeding caused by arteriovenous malformations in patients with left ventricular assist devices.
|
Academic Article
|
Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome.
|
Academic Article
|
Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated mutation carriers.
|
Academic Article
|
Transthyretin cardiac amyloidosis: pathogenesis, treatments, and emerging role in heart failure with preserved ejection fraction.
|
Academic Article
|
Use of a coronary sinus lead and biventricular ICD to correct a sensing abnormality in a patient with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
|
Academic Article
|
Angiotensin II blockade and aortic-root dilation in Marfan's syndrome.
|
Academic Article
|
Current treatment of adult Duchenne muscular dystrophy.
|
Academic Article
|
Baseline Characteristics Predict the Presence of Amyloid on Endomyocardial Biopsy.
|
Academic Article
|
Evaluation of Structural Progression in Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy.
|
Academic Article
|
Characterization of microsatellite markers flanking FBN1: utility in the diagnostic evaluation for Marfan syndrome.
|
Academic Article
|
Genetic testing for dilated cardiomyopathy in clinical practice.
|
Academic Article
|
Approach to family screening in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
|
Academic Article
|
Short-term effects of right-left heart sequential cardiac resynchronization in patients with heart failure, chronic atrial fibrillation, and atrioventricular nodal block.
|
Academic Article
|
Mutations in Alstr?m protein impair terminal differentiation of cardiomyocytes.
|
Academic Article
|
Surgical Correction of Tricuspid Regurgitation in Patients with ARVD/C.
|
Academic Article
|
A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2.
|
Academic Article
|
Novel and highly lethal NKX2.5 missense mutation in a family with sudden death and ventricular arrhythmia.
|
Academic Article
|
Loss of elastic fiber integrity and reduction of vascular smooth muscle contraction resulting from the upregulated activities of matrix metalloproteinase-2 and -9 in the thoracic aortic aneurysm in Marfan syndrome.
|
Academic Article
|
Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
|
Academic Article
|
Pregnancy course and outcomes in women with arrhythmogenic right ventricular cardiomyopathy.
|
Academic Article
|
Noncanonical TGF? signaling contributes to aortic aneurysm progression in Marfan syndrome mice.
|
Academic Article
|
Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism.
|
Academic Article
|
Yield of serial evaluation in at-risk family members of patients with ARVD/C.
|
Academic Article
|
Comprehensive Versus Targeted Genetic Testing in Children with Hypertrophic Cardiomyopathy.
|
Academic Article
|
Genetic Evaluation of Cardiomyopathy-A Heart Failure Society of America Practice Guideline.
|
Academic Article
|
Marfan's syndrome.
|
Academic Article
|
Arrhythmogenic right ventricular dysplasia: a United States experience.
|
Academic Article
|
Use of genetics in the clinical evaluation of cardiomyopathy.
|
Academic Article
|
Comprehensive desmosome mutation analysis in north americans with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
|
Academic Article
|
LMNA-associated cardiocutaneous progeria: an inherited autosomal dominant premature aging syndrome with late onset.
|
Academic Article
|
Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy.
|
Academic Article
|
No major role for rare plectin variants in arrhythmogenic right ventricular cardiomyopathy.
|
Academic Article
|
Seven factors predict a delayed diagnosis of cardiac amyloidosis.
|
Academic Article
|
Cardiac Management of the Patient With Duchenne Muscular Dystrophy.
|
Academic Article
|
Four-Chamber Intracardiac Thrombi Complicating Wild-Type TTR Amyloidosis.
|
Academic Article
|
Regional Variation in RBM20 Causes a Highly Penetrant Arrhythmogenic Cardiomyopathy.
|
Academic Article
|
Transthyretin Stabilization by AG10 in Symptomatic Transthyretin Amyloid?Cardiomyopathy.
|
Academic Article
|
A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy.
|
Academic Article
|
Correction: Genetic evaluation of cardiomyopathy: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG).
|
Academic Article
|
2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy.
|
Academic Article
|
Genetic aetiologies should be considered in paediatric cases of acute heart failure presumed to be myocarditis.
|
Academic Article
|
Definition and treatment of arrhythmogenic cardiomyopathy: an updated expert panel report.
|
Academic Article
|
Ankyrin-B dysfunction predisposes to arrhythmogenic cardiomyopathy and is amenable to therapy.
|
Academic Article
|
Positive family history decreases diagnosis time by over 200.
|
Academic Article
|
Arrhythmogenic Right Ventricular Cardiomyopathy-Associated Desmosomal Variants Are Rarely De Novo.
|
Academic Article
|
Therapeutic Modulation of the Immune Response in Arrhythmogenic Cardiomyopathy.
|
Academic Article
|
Tnni3k alleles influence ventricular mononuclear diploid cardiomyocyte frequency.
|
Academic Article
|
SSRI/SNRI Therapy is Associated With a Higher Risk of Gastrointestinal Bleeding in LVAD Patients.
|
Academic Article
|
2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy: Executive summary.
|
Academic Article
|
FLNC truncations cause arrhythmogenic right ventricular cardiomyopathy.
|
Academic Article
|
Safety and Utility of Cardiopulmonary Exercise Testing in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia.
|
Academic Article
|
Genetic Dilated Cardiomyopathy Due to TTN Variants Without Known Familial Disease.
|
Academic Article
|
Sudden Cardiac Death Prediction in Arrhythmogenic Right Ventricular Cardiomyopathy: A Multinational Collaboration.
|
Academic Article
|
Multivalvular Pulsus Alternans.
|
Academic Article
|
Cadherin 2-Related Arrhythmogenic Cardiomyopathy: Prevalence and Clinical Features.
|
Academic Article
|
Exercise triggers CAPN1-mediated AIF truncation, inducing myocyte cell death in arrhythmogenic cardiomyopathy.
|
Academic Article
|
Influence of Panel Selection on Yield of Clinically Useful Variants in Arrhythmogenic Right Ventricular Cardiomyopathy Families.
|
Academic Article
|
Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR-ACT) and long-term extension study.
|
Academic Article
|
The prevalent I686T human variant and loss-of-function mutations in the cardiomyocyte-specific kinase gene TNNI3K cause adverse contractility and concentric remodeling in mice.
|
Academic Article
|
Management of heart failure in cardiac amyloidosis using an ambulatory diuresis clinic.
|
Academic Article
|
Genetic and Phenotypic Landscape of Peripartum Cardiomyopathy.
|
Academic Article
|
Drug Discovery and Development in Rare Diseases: Taking a Closer Look at the Tafamidis Story.
|
Academic Article
|
International Evidence Based Reappraisal of Genes Associated With Arrhythmogenic Right Ventricular Cardiomyopathy Using the Clinical Genome Resource Framework.
|
Academic Article
|
Evidence-Based Assessment of Genes in Dilated Cardiomyopathy.
|
Academic Article
|
Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR).
|
Academic Article
|
Correction to: Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR).
|
Academic Article
|
Hypermobile Ehlers-Danlos syndromes: Complex phenotypes, challenging diagnoses, and poorly understood causes.
|
Academic Article
|
Endomyocardial Biopsy Characterization of Heart?Failure With Preserved Ejection?Fraction and Prevalence of Cardiac Amyloidosis.
|
Concept
|
Molecular Targeted Therapy
|
Concept
|
High-Throughput Nucleotide Sequencing
|
Concept
|
Exome
|
Concept
|
Cardiac Resynchronization Therapy
|
Concept
|
Walk Test
|
Concept
|
Laser Capture Microdissection
|
Concept
|
CRISPR-Cas Systems
|
Concept
|
Connectin
|
Concept
|
Filamins
|
Concept
|
Vascular Remodeling
|
Concept
|
Gene Editing
|
Concept
|
RNAi Therapeutics
|
Concept
|
Sildenafil Citrate
|
Concept
|
Loss of Function Mutation
|
Concept
|
Fibrillins
|
Concept
|
Fibrillin-1
|
Concept
|
Homeobox Protein Nkx-2.5
|
Concept
|
Mice, 129 Strain
|
Concept
|
Haploinsufficiency
|
Academic Article
|
Natural history and progression of transthyretin amyloid cardiomyopathy: insights from ATTR-ACT.
|
Academic Article
|
Phenotypic Expression, Natural History, and Risk Stratification of Cardiomyopathy Caused by Filamin C Truncating Variants.
|
Academic Article
|
Wild-Type Transthyretin Cardiac Amyloidosis Is Associated with Increased Antecedent Physical Activity.
|
Academic Article
|
Prevalence and Cumulative Risk of Familial Idiopathic Dilated Cardiomyopathy.
|
Academic Article
|
The response to cardiac resynchronization therapy in LMNA cardiomyopathy.
|
Academic Article
|
A pragmatic implementation research study for In Our DNA SC: a protocol to identify multi-level factors that support the implementation of a population-wide genomic screening initiative in diverse populations.
|
Academic Article
|
How did transthyretin amyloid cardiomyopathy progress in patients who took placebo in the study ATTR-ACT? A plain language summary.
|
Academic Article
|
ATTR Epidemiology, Genetics, and Prognostic Factors.
|
Academic Article
|
A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy.
|
Academic Article
|
PLEKHM2 Loss-of-Function Is Associated With Dilated Cardiomyopathy.
|
Academic Article
|
Counseling Family Members and Monitoring for Evidence of Disease in Asymptomatic Carriers of Amyloid Transthyretin Cardiac Amyloidosis.
|
Academic Article
|
Knowledge of Genome Sequencing and Trust in Medical Researchers Among Patients of Different Racial and Ethnic Groups With Idiopathic Dilated Cardiomyopathy.
|
Academic Article
|
Efficacy and Safety of ARRY-371797 in LMNA-Related Dilated Cardiomyopathy: A Phase 2 Study.
|
Academic Article
|
Lessons Learned from the Pilot Phase of a Population-Wide Genomic Screening Program: Building the Base to Reach a Diverse Cohort of 100,000 Participants.
|
Academic Article
|
Long-Term Efficacy and Safety of ARRY-371797 (PF-07265803) in Patients With Lamin A/C-Related Dilated Cardiomyopathy.
|
Academic Article
|
Efficacy and Safety of Angiotensin Receptor Blockers in a Pre-Clinical Model of Arrhythmogenic Cardiomyopathy.
|
Academic Article
|
Plain Language Summary of Publication of the safety and efficacy of ARRY-371797 in people with dilated cardiomyopathy and a faulty LMNA gene.
|
Academic Article
|
Effectiveness of the Family Heart Talk Communication Tool in Improving Family Member Screening for Dilated Cardiomyopathy: Results of a Randomized Trial.
|